Clinical AI for Avoidable Patient Harm

Jvion's unique clinical AI platform powers a robust set of solutions that identify patients on the cusp of becoming high-risk for a multitude of clinical events and what can be done to change their trajectory.  The Jvion CORE™ enables clinical staff, care teams, and other business stakeholders to focus attention, resources, and individualized interventions on patients whose outcomes can be improved or that would experience severe outcomes if not intervened on. 

The Jvion CORE—can be quickly applied to a multitude of health events including but not limited to:  Population Heath, Avoidable Utilization, Readmissions, Hospice & Palliative Care, COVID Vaccination Prioritization, and more. 

With COVID response front and center across healthcare and communities more broadly, our Vaccination Prioritization Index (VPI) considers the CDC’s recommendations for who should be prioritized for the limited supply of vaccines. Once healthcare workers and long-term care facility residents are vaccinated, the next phases will prioritize essential workers, the elderly, and those with underlying medical conditions. At each phase, Jvion’s VPI helps determine which locations need more vaccines based on the makeup of the community and helps providers target their vaccination outreach to their patients at the greatest risk.

Recognized by KLAS, Frost & Sullivan, IDC, and Blackbook as a leader in the clinical and prescriptive AI space,  Jvion has delivered value across settings with hospitals reporting average reductions of 30% in avoidable harm incidents and avoidable cost savings of $6.3 million a year; payers reducing the volume of care manager outreach and thousands in PMPM savings across member populations.